LAVAL,
Quebec, July 27, 2022 /PRNewswire/ -- Bausch
Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will
release its second-quarter financial results on Tuesday, Aug. 9, 2022. Bausch Health will host a
conference call and live web cast at 8:00
a.m. ET to discuss the results and provide a business
update. All materials will be made available on the Investor
Relations section of the Bausch Health website prior to the start
of the call.
Conference Call Details
|
Date:
|
Tuesday, Aug. 9,
2022
|
|
|
|
Time:
|
8:00 a.m. ET
|
|
|
|
Webcast:
|
http://ir.bauschhealth.com/events-and-presentations
|
|
|
|
Participant Event
Dial-in:
|
+1 (888) 317-6003
(United States)
+1 (412) 317-0088
(International)
+1 (866) 284-3684
(Canada)
|
|
|
|
Participant
Passcode:
|
10163321
|
|
|
|
Replay
Dial-in:
|
+1 (877) 344-7529
(United States)
+1 (412) 317-0088
(International)
+1 (855) 669-9658
(Canada)
|
|
|
|
Replay
Passcode:
|
9325022 (replay
available until Aug. 16, 2022)
|
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global
diversified pharmaceutical company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of products primarily in
gastroenterology, hepatology, neurology, dermatology, international
pharmaceuticals and eye health, through our approximately 90%
ownership of Bausch + Lomb Corporation. With our leading durable
brands, we are delivering on our commitments as we build an
innovative company dedicated to advancing global health. For more
information, visit www.bauschhealth.com and connect with us on
Twitter and LinkedIn.
|
Investor
Contact:
|
Media Contact:
|
|
Christina Cheng
|
Kevin
Wiggins
|
|
ir@bauschhealth.com
|
corporate.communications@bauschhealth.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bausch-health-companies-inc-will-release-second-quarter-2022-financial-results-on-aug-9-301594842.html
SOURCE Bausch Health Companies Inc.